The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...

Stock prices for Novo Nordisk fell by about 3% at market open after the Biden administration selected its revolutionary drugs ...

Medicare will negotiate drug prices for popular medications like Ozempic and Wegovy, aiming to save billions for taxpayers ...

It’s taken LVMH nearly a year-and-a-half to regain its spot as Europe’s biggest stock from Novo Nordisk A/S.

Danish businesses are concerned about a possible trade conflict with the United States over Greenland, a major lobby group ...

The CEO of obesity drugmaker Novo Nordisk and heads of other Danish companies met on Thursday with Denmark's Prime Minister ...

We recently published an article titled Jim Cramer Discussed These 21 Stocks As Bond Yields Soared. In this article, we are ...

Indeed, Ozempic and Wegovy may well be in the news in the coming months—if Trump imposes the massive tariffs on Denmark that ...

Novo Nordisk should deliver a 24% CAGR over two years, driven by robust obesity drug market growth and improved operational performance, with an intrinsic value implying a 29% safety margin.

NN-9542 is under clinical development by Novo Nordisk and currently in Phase I for Diabetes. According to GlobalData, Phase I drugs for Diabetes have a 61% phase transition success rate (PTSR) ...

North Carolina stuck to the script in 2024. Drug manufacturing and alternative energy projects have accounted for several of the biggest state-backed economic projects in recent years, and this ...